Friday, November, 16, 2018 05:38:27

Contribution By Ojaswita Kutepatil


Cobra Biologics with GE Healthcare and CPI to develop AAV vectors

Cobra Biologics, an international biologics and pharmaceuticals contract development and manufacturing organization recently announced that it will be collaborating with UK-based technology innovation foundation, Centre for Process Innovation (CPI) and GE Healthcare Life Sciences. The aim of the three-way partnership is to increase the strength …

Tris Pharma acquires NextWave Pharmaceuticals, expands ADHD portfolio

Tris Pharma, technology-based therapeutic products developer recently acquired NextWave Pharmaceuticals, a subsidiary of Pfizer, the American pharmaceutical corporation. The sum involved in the acquisition has not been disclosed. According to reliable sources, the acquisition will enable Tris Pharma to expand its product offering in the …

Amicus Therapeutics cuts deal with Celenex, enters gene therapy

Amicus Therapeutics has recently unveiled that it has acquired Celenex, a clinical-stage gene therapy company and a spin out of the Ohio-based Nationwide Children’s Hospital, in a multimillion dollar deal. Reportedly, the deal expands Amicus portfolio of 10 gene therapy programs that are originally discovered …